As of 2024-12-11, the Relative Valuation of AxoGen Inc (AXGN) is (10.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.84 USD, the upside of AxoGen Inc based on Relative Valuation is -173.1%.
The range of the Relative Valuation is (11.75) - (10.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.1x - 41.8x | 38.8x |
| Forward P/E multiples | 26.1x - 33.0x | 27.8x |
| Fair Price | (11.75) - (10.73) | (10.84) |
| Upside | -179.2% - -172.3% | -173.1% |
| Date | P/E |
| 2024-12-10 | -45.20 |
| 2024-12-09 | -45.13 |
| 2024-12-06 | -45.86 |
| 2024-12-05 | -45.13 |
| 2024-12-04 | -45.62 |
| 2024-12-03 | -44.42 |
| 2024-12-02 | -44.79 |
| 2024-11-29 | -42.76 |
| 2024-11-27 | -43.28 |
| 2024-11-26 | -41.87 |
| 2024-11-25 | -41.44 |
| 2024-11-22 | -41.04 |
| 2024-11-21 | -40.30 |
| 2024-11-20 | -39.68 |
| 2024-11-19 | -39.22 |
| 2024-11-18 | -39.37 |
| 2024-11-15 | -38.88 |
| 2024-11-14 | -38.36 |
| 2024-11-13 | -38.57 |
| 2024-11-12 | -40.82 |
| 2024-11-11 | -42.97 |
| 2024-11-08 | -38.94 |
| 2024-11-07 | -40.82 |
| 2024-11-06 | -47.16 |
| 2024-11-05 | -46.02 |
| 2024-11-04 | -43.68 |
| 2024-11-01 | -42.91 |
| 2024-10-31 | -43.07 |
| 2024-10-30 | -44.45 |
| 2024-10-29 | -42.94 |
| 2024-10-28 | -42.88 |
| 2024-10-25 | -40.94 |
| 2024-10-24 | -40.94 |
| 2024-10-23 | -40.36 |
| 2024-10-22 | -40.85 |
| 2024-10-21 | -40.45 |
| 2024-10-18 | -40.48 |
| 2024-10-17 | -40.73 |
| 2024-10-16 | -44.48 |
| 2024-10-15 | -44.14 |
| 2024-10-14 | -43.83 |
| 2024-10-11 | -45.25 |
| 2024-10-10 | -41.84 |
| 2024-10-09 | -42.24 |
| 2024-10-08 | -41.87 |
| 2024-10-07 | -42.14 |
| 2024-10-04 | -42.05 |
| 2024-10-03 | -41.04 |
| 2024-10-02 | -43.50 |
| 2024-10-01 | -44.02 |